These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24228009)

  • 1. Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.
    Falcone C; Bozzini S; Guasti L; D'Angelo A; Capettini AC; Paganini EM; Falcone R; Moia R; Gazzaruso C; Pelissero G
    ScientificWorldJournal; 2013; 2013():584504. PubMed ID: 24228009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Plasma Betatrophin Levels and Coronary and Peripheral Artery Disease.
    Niki H; Kishimoto Y; Ibe S; Saita E; Sasaki K; Miura K; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2019 Jun; 26(6):573-581. PubMed ID: 30518729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
    Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
    Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between soluble receptor for advanced glycation end products (sRAGE) and coronary and cerebral atherosclerosis].
    Yang SH; Han XJ; Hu HY; Chen W; Yang CZ; Tian JP; Guo CX
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3062-3067. PubMed ID: 31648447
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases.
    Kishimoto Y; Ibe S; Saita E; Sasaki K; Niki H; Miura K; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    Dis Markers; 2018; 2018():6138124. PubMed ID: 30159103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.
    Miyazaki Y; Saita E; Kishimoto Y; Ibe S; Seki T; Miura K; Suzuki-Sugihara N; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2018 Sep; 25(9):821-828. PubMed ID: 29367522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography.
    Saleh A; Makhamreh H; Qoussoos T; Alawwa I; Alsmady M; Salah ZA; Shakhatreh A; Alhazaymeh L; Jabber M
    Medicine (Baltimore); 2018 Jul; 97(29):e11519. PubMed ID: 30024534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Tsirebolos G; Tsoporis JN; Drosatos IA; Izhar S; Gkavogiannakis N; Sakadakis E; Triantafyllis AS; Parker TG; Rallidis LS; Rizos I
    Int J Cardiol; 2023 Apr; 376():127-133. PubMed ID: 36758863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
    Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
    Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.
    Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Sato A; Imaizumi T
    Diabetes Metab Res Rev; 2007 Jul; 23(5):368-71. PubMed ID: 17024691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden.
    Basta G; Del Turco S; Navarra T; Mazzarisi A; Cocci F; Coceani M; Bianchi M; Schlueter M; Marraccini P
    J Atheroscler Thromb; 2012; 19(10):941-8. PubMed ID: 22785051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
    Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography characteristics of coronary artery atherosclerosis in subjects with lower extremity peripheral artery disease and no cardiac symptoms.
    Miszalski-Jamka T; Lichołai S; Karwat K; Laskowicz B; Okraska-Bylica A; Wilkosz T; Konieczyńska M; Trystuła M; Słowik L; Urbańczyk M; Pasowicz M; Jaźwiec P
    Pol Arch Med Wewn; 2013; 123(12):657-63. PubMed ID: 24185038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease.
    Imori Y; Akasaka T; Ochiai T; Oyama K; Tobita K; Shishido K; Nomura Y; Yamanaka F; Sugitatsu K; Okamura N; Mizuno S; Arima K; Suenaga H; Murakami M; Tanaka Y; Matsumi J; Takahashi S; Tanaka S; Takeshita S; Saito S
    Am J Cardiol; 2014 Jan; 113(1):30-5. PubMed ID: 24157190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.